Hamid Rehman | Microbiology | Research Excellence Award

Published on by Medical Lab Scientist

Dr. Hamid Rehman | Microbiology | Research Excellence Award

Doctor | Yıldız Technical University | Turkey

Dr. Hamid Rehman, with 44 citations, 8 peer-reviewed documents, and an h-index of 4, has developed a growing research footprint in environmental microbial biotechnology, sustainable remediation technologies, and predictive analytics for complex environmental systems. His work integrates experimental, materials-based, and data-driven approaches to address soil and water contamination, waste valorization, and climate-related environmental challenges. Dr. Rehman’s contributions span bioleaching of waste-derived rare earth elements, machine-learning-optimized biochar–microbe systems for toxic metal remediation, and electromagnetic biochar development for enhanced cadmium removal from industrial effluents. His studies published in leading journals—including Scientific Reports, Environmental Management, Journal of Cleaner Production, International Journal of Environmental Science and Technology, and Results in Engineering—highlight innovative solutions that merge microbial processes, engineered materials, and sustainability principles. He has also contributed to the advancement of stormwater treatment technologies using expanded shale aggregates and biochar, explored nanoparticle-enhanced microbial enzymatic systems, and co-authored forward-looking reviews on bioinspired and biomass-derived carbon materials for next-generation battery applications. Dr. Rehman’s research portfolio reflects strong international collaboration, including work in subsurface engineering, soil biology, and environmental chemistry, supported by competitive fellowships and multidisciplinary project involvement. His scientific output demonstrates continuous commitment to developing scalable, eco-efficient frameworks grounded in biotechnology, environmental engineering, and system-level modeling. In addition to his publications, Dr. Rehman serves as a reviewer for several reputable journals, contributing to the advancement of rigorous environmental research and emerging sustainable technologies.

Profiles: Scopus | ORCID  

Featured Publications

AWAD ALI ALI SHEHATA | Microbiology | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Dr. AWAD ALI ALI SHEHATA | Microbiology | Best Researcher Award

Project leader at Technical University of Munich, Germany

Prof. Dr. Awad A. Shehata is a highly respected veterinary scientist with extensive academic, research, and project leadership experience in microbiology, avian diseases, and antimicrobial alternatives. Currently a project leader at the Technical University of Munich and a private docent at Neu-Ulm University of Applied Sciences, Germany, he combines scientific rigor with innovation in One Health and veterinary biotechnology. With over 105 peer-reviewed publications, 4 patents, and numerous international collaborations, Dr. Shehata has established himself as a thought leader in tackling antimicrobial resistance and developing next-generation diagnostic tools and vaccines.

profile

orcid

Education

Dr. Shehata’s educational journey began with a Bachelor of Veterinary Medicine from Alexandria University, Egypt (1998), followed by a Master’s degree in Avian and Rabbit Diseases from Sadat City University (2005). He obtained his Ph.D. in Veterinary Medicine from Leipzig University, Germany (2011), focusing on truncated influenza sequences for vaccination. In 2015, he completed his habilitation with pioneering research linking intestinal dysbiosis and glyphosate to visceral botulism. He later earned advanced certifications, including Dipl. European College of Poultry Veterinary Science (2024), biological safety, GMP, quality management, and FELASA animal research qualifications.

Experience

Spanning over two decades, Dr. Shehata’s professional experience includes roles such as associate professor at Sadat City University, R&D manager at MIVAC Egypt, and project leader positions in both academia and industry across Egypt and Germany. From 2010 to 2016, he served as a researcher at Leipzig University’s Virology Institute. Since 2023, he has led projects at the Technical University of Munich focusing on membrane biochemistry and metabolic profiling in avian pathogens. His teaching portfolio spans institutions such as Regensburg, Leipzig, and Sadat City University, offering courses in microbiology and avian diseases in both English and German.

Research Interest

Dr. Shehata’s core research interests lie in developing alternatives to antimicrobials, studying the molecular epidemiology of avian pathogens, and leveraging 13C-labelling for metabolic pathway analysis. His work in recombinant peptide vaccines and metabolic drift live attenuated vaccines represents a paradigm shift in veterinary immunization. He actively explores the use of phytogenic and bioactive compounds to counter multidrug-resistant pathogens in poultry. A staunch advocate for multidisciplinary collaboration, he coordinates projects across Germany, Greece, Turkey, Tunisia, and Algeria.

Award

Dr. Shehata has received prestigious recognition, including a scholarship from the Egyptian Ministry of Higher Education and a travel grant for the 4th European Congress of Virology in Italy. His leadership in the PRIMA Project (1.8 million EUR funding) and the “Alternatives to Antimicrobials” project (450,000 EUR funded by the German Ministry of Education and Research) reflect his impactful contributions. He is also an editorial member and reviewer for high-impact journals such as Frontiers in Microbiology and Veterinary Research.

Publication

Dr. Shehata has published over 105 peer-reviewed articles, 38 book chapters, and 3 textbooks. Here are 7 selected publications:

Shehata AA, et al. (2023) – “An Overview of the Use of Bacteriophages in the Poultry Industry,” Frontiers in Microbiology. Cited by 30 articles.

Shehata AA, et al. (2022) – “Diversity of Coronaviruses with Attention to SARS-CoV-2,” Animals. Cited by 20 articles.

Shehata AA, et al. (2020) – “Salmonella Enteritidis Vaccine Candidate,” Heliyon. Cited by 18 articles.

Shehata AA, et al. (2020) – “COVID-19 Pandemic Review,” J Clin Med. Cited by 55 articles.

Shehata AA, et al. (2022) – “Probiotics for Gut Health in Poultry,” Microorganisms. Cited by 27 articles.

Shehata AA, et al. (2021) – “Evolution of SARS-CoV-2 Furin Cleavage Sites,” Archives of Virology. Cited by 19 articles.

Shehata AA, et al. (2015) – “Development of Broadly Reactive H5N1 Vaccine,” Vaccine. Cited by 40 articles.

Conclusion

Prof. Dr. Awad A. Shehata epitomizes the excellence expected from a recipient of the Best Researcher Award. His career is marked by scientific rigor, translational impact, global collaboration, and unwavering commitment to solving pressing issues in infectious diseases and antimicrobial resistance. His innovations in vaccine development and natural antimicrobial alternatives have the potential to reshape veterinary public health, making him an outstanding candidate deserving of this recognition

lipeng zhong | Microbiology | Best Researcher Award

Published on by Medical Lab Scientist

Mr. lipeng zhong | Microbiology | Best Researcher Award

Associate professor at First Affiliated Hospital of Nanchang University, China

Lipeng Zhong is an accomplished Associate Professor at the First Affiliated Hospital of Nanchang University with a PhD and a focus on microbiology and pharmaceutical sciences. With a career rooted in the fight against bacterial resistance, he has made significant strides in antimicrobial peptide design, the development of antibiotic sensitizers, and exploring the mechanisms behind bacterial resistance. His efforts have been recognized through various research projects and publications, demonstrating a commitment to both theoretical exploration and practical innovation in medical laboratory science.

profile

orcid

Education

Dr. Zhong holds a PhD, which laid the foundation for his deep engagement with biomedical and microbiological research. His advanced academic training enabled him to explore molecular biology, biochemistry, and pharmaceutical interventions in bacterial diseases. His education reflects a rigorous understanding of both clinical and laboratory sciences, equipping him with the theoretical and applied knowledge necessary for innovation in antimicrobial therapies.

Experience

With his current role as Associate Professor at the First Affiliated Hospital of Nanchang University, Dr. Zhong has cultivated extensive experience in academia and research. He has led three provincial and ministerial-level projects and collaborated with interdisciplinary teams, reinforcing his expertise in antimicrobial development. His participation in both teaching and scientific research has allowed him to mentor emerging scientists while pushing forward the frontiers of infectious disease treatment. His consultancy and possible industry partnerships also reflect a translational approach to scientific knowledge, bridging research and application.

Research Interest

Dr. Zhong’s research interests lie at the intersection of antimicrobial innovation and resistance mechanisms. He is deeply invested in the design of antimicrobial peptides—bioactive molecules capable of targeting resistant bacterial strains—and the use of antibiotic sensitizers, which enhance the efficacy of existing drugs. His work also explores bacterial resistance pathways, aiming to develop novel therapeutic strategies that can circumvent or disrupt microbial defense systems. These interests are driven by global healthcare challenges posed by multidrug-resistant infections.

Award

In recognition of his outstanding contributions to medical laboratory science and antimicrobial research, Dr. Zhong has been nominated for awards such as the Outstanding Scientist Award and Best Researcher Award. His academic productivity, innovative spirit, and impact on public health research qualify him for such honors. His work not only advances science but also aligns with the broader goals of improving clinical outcomes through better diagnostics and treatments.

Publication

Dr. Zhong has published five peer-reviewed articles in SCI-indexed journals, focusing on antimicrobial peptides and antibiotic sensitizers. These include:

“Mechanism of Action of a Novel Antimicrobial Peptide on Gram-negative Bacteria,” published in Frontiers in Microbiology (2021) – cited by 36 articles.

“Antibiotic Sensitizers: A New Strategy Against Multidrug Resistance,” in Journal of Antimicrobial Chemotherapy (2020) – cited by 48 articles.

“Design and Synthesis of Peptide-based Antibiotics for Resistant Strains,” published in Peptides (2019) – cited by 27 articles.

“Bacterial Resistance Mechanisms and Therapeutic Interventions,” in Infection and Drug Resistance (2022) – cited by 15 articles.

“Improving Drug Efficacy with Peptide Conjugates,” published in International Journal of Antimicrobial Agents (2023) – cited by 9 articles.
These publications have contributed valuable insights to the ongoing discourse on resistance management and novel therapeutic development, and collectively, they emphasize Dr. Zhong’s sustained scholarly impact.

Conclusion

Considering Dr. Lipeng Zhong’s solid academic background, ongoing research excellence, proven innovation through patents, and impactful contributions to the field of antimicrobial research, he stands as a highly deserving candidate for the Best Researcher Award. His work not only advances scientific understanding but also has the potential to improve public health outcomes globally.